Literature DB >> 3749625

Krypton red laser photocoagulation in selected cases of central serous chorioretinopathy.

M M Slusher.   

Abstract

Krypton red laser photocoagulation was carried out in 15 eyes with chronic, uncomplicated monocular central serous chorioretinopathy. All patients had vocations requiring excellent binocular vision, and could not work effectively with their current visual acuity. Krypton red was selected as the most suitable photocoagulative source, given the nature of the disease, the tissue-selectiveness of krypton red laser on the retinal pigment epithelium, and the relative inability of the macular luteal pigment and capillary beds of the inner retinal layers to absorb the red wavelength. Visual acuity improved in all 15 eyes, and to at least 20/30 (6/9) in 12 eyes (80%). The visible effects of krypton red laser photocoagulation on the retinal pigment epithelium were minimal and, although nine eyes had had focal leaks within 100 microns of the foveal avascular zone and 12 eyes had been photocoagulated within the maculopapillar bundle, no adverse clinical effects were observed. In carefully selected cases, then, krypton red laser photocoagulation appears to be suitable and safe for the treatment of central serous chorioretinopathy in a tissue-specific manner.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3749625     DOI: 10.1097/00006982-198600620-00003

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  4 in total

Review 1.  Bullous variant of idiopathic central serous chorioretinopathy.

Authors:  D K Sahu; P Namperumalsamy; G F Hilton; N F de Sousa
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

2.  Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [ISRCTN84128484].

Authors:  Lalit Verma; Rajesh Sinha; Pradeep Venkatesh; H K Tewari
Journal:  BMC Ophthalmol       Date:  2004-10-29       Impact factor: 2.209

Review 3.  Advances in the treatment of central serous chorioretinopathy.

Authors:  Marwan A Abouammoh
Journal:  Saudi J Ophthalmol       Date:  2015-01-24

4.  Combined Argon Laser and Low Dose Acetylsalicylic acid in Treatment of Acute Central Serous Chorioretinopathy.

Authors:  Alahmady Hamad Alsmman; Engy Mohamed Mostafa; Amr Mounir
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.